WATCH: Senate hearing on the nomination of Robert Califf as commissioner of FDA
President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic.
U.S. expands Pfizer COVID boosters, allowing third dose to people as young as 16
The Food and Drug Administration on Thursday cleared an extra dose for those ages 16 and 17, and the Centers for Disease Control and Prevention rapidly endorsed a booster for those ages.
FDA expands Pfizer COVID booster, opens extra dose to age 16
The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination.
FDA panel review final hurdle for Merck’s COVID-19 pill
U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients.
Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.
Califf served as FDA commissioner for the last 11 months of President Barack Obama’s second term.
Pfizer is asking U.S. regulators to allow boosters of its COVID-19 vaccine for anyone 18 or older. Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine…
The Centers for Disease Control and Prevention advisory panel will have a discussion and vote Tuesday on the use of the Pfizer COVID-19 vaccine for children between the ages of five to 11.
The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.
Additional Support Provided By:
